Xfogen Pharma Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2014.
2014 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Xfogen Pharma Private Limited

Xfogen Pharma Private Limited, a active private limited company, was established on 25 September 2014 in New Delhi, Delhi, India. Engaging in other human health activities within the healthcare sector, it holds CIN: U85190DL2014PTC271890. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Tapas Kumar Mukherjee (Director), Tapan Kumar Mukherjee (Additional Director). Past directors included Kamal Sharma, Asha Rani. It is based at Flat No 230, Swayam Sewa Group Housing Society Jhilmil Colony, New Delhi, Delhi, 110095.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85190DL2014PTC271890

  • Registration Number

    271890

  • Incorporation Date

    25 September 2014

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 6 Months
Company report

Xfogen Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Xfogen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Xfogen Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Tapas Kumar Mukherjee Director 26 Nov 2014 Current
Tapan Kumar Mukherjee Additional Director 27 Sep 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Dec 2014 Past
Pramod Abcsdd Director 01 Dec 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Xfogen Pharma.

Enhance accessibility to Xfogen Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Xfogen Pharma revenue growth over time
Xfogen Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Xfogen Pharma?

Unlock access to Xfogen Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Xfogen Pharma?

Unlock and access historical data on people associated with Xfogen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Xfogen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xfogen Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Xfogen Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Tapas Kumar Mukherjee was appointed as a Director was appointed as a Director on 26 Nov 2014 & has been associated with this company since 11 years 4 months . was documented.

  • Director Appointment

    Tapan Kumar Mukherjee was appointed as a Additional Director was appointed as a Additional Director on 27 Sep 2014 & has been associated with this company since 11 years 6 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Xfogen Pharma Private Limited was registered on 25 Sep 2014 with Roc Delhi & aged 11 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Xfogen Pharma Private Limited?

The CIN of Xfogen Pharma Private Limited is U85190DL2014PTC271890.

Where is Xfogen Pharma Private Limited headquartered?

Xfogen Pharma Private Limited is headquartered at Flat No 230, Swayam Sewa Group Housing Society Jhilmil Colony, New Delhi, Delhi, 110095.

When was Xfogen Pharma Private Limited incorporated?

Xfogen Pharma Private Limited was incorporated on 25 September 2014.

Who are the current directors of Xfogen Pharma Private Limited?

The current directors of Xfogen Pharma Private Limited are

What is the primary industry of Xfogen Pharma Private Limited?

The primary industry of Xfogen Pharma Private Limited is Healthcare.

Is Xfogen Pharma Private Limited a listed company?

Xfogen Pharma Private Limited is unlisted.

What is the capital structure of Xfogen Pharma Private Limited?

The authorized capital of Xfogen Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Xfogen Pharma Private Limited?

The compliance status of Xfogen Pharma Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available